Ticker Details
Roivant Sciences Ltd. Common Shares
IPO Date:	January 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$21.55B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.23 | 2.37%
Avg Daily Range (30 D):	$0.52 | 1.78%
Avg Daily Range (90 D):	$0.47 | 1.74%

Institutional Daily Volume
Avg Daily Volume:	3.13M
Avg Daily Volume (30 D):	4.71M
Avg Daily Volume (90 D):	4.64M

Trade Size
Avg Trade Size (Sh.):	140
Avg Trade Size (Sh.) (30 D):	99
Avg Trade Size (Sh.) (90 D):	94

Institutional Trades
Total Institutional Trades:	4,234
Avg Institutional Trade:	$4.23M
Avg Institutional Trade (30 D):	$7.32M
Avg Institutional Trade (90 D):	$6.3M
Avg Institutional Trade Volume:	.3M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$11.36M
Avg Closing Trade (30 D):	$20.2M
Avg Closing Trade (90 D):	$27.26M
Avg Closing Volume:	815.49K

News

May 18, 2026 @ 5:00 PM Myasthenia Gravis Market Set to Surpass USD 16 Bil... Source: Delveinsight

Apr 15, 2026 @ 5:00 PM Generalized Myasthenia Gravis Market on the Brink ... Source: Delveinsight

Apr 2, 2026 @ 9:00 AM Priovant Expands Brepocitinib Development Program ... Source: Na

Mar 28, 2026 @ 7:00 PM New England Journal of Medicine Publishes Positive... Source: Priovant Therapeutics / Roivant Sciences

Mar 5, 2026 @ 7:42 PM 9 Biotech Stocks Trading Far Below Fair Value With... Source: David Wagner

Financials
	TTM	Q4 2026	FY 2026
Basic EPS	$-.43	$.45	$-.43
Diluted EPS	$-.54	$.34	$-.54
Revenue	$8.26M	$2.52M	$8.26M
Gross Profit
Net Income / Loss	$-397.91M	$355.74M	$-397.91M
Operating Income / Loss	$-515.07M	$415.24M	$-515.07M
Cost of Revenue
Net Cash Flow	$-1298.45M	$-59.1M	$-1298.45M
PE Ratio